References
- Korn D. Congenital hypoplastic thrombocytopenia. Am J Clin Pathol. 1962 Apr;37:405-13. PubMed | Google Scholar
- Gewirtz AM, Hoffman R. Human megakaryocyte production: cell biology and clinical considerations. Hematol Oncol Clin North Am. 1990 Feb;4(1):43-64. PubMed | Google Scholar
- Trimble MS, Glynn MFX, Brain MC. Amegakaryocytic thrombocytopenia
of 4 years duration: successful treatment with antithymocyte globulin. Am J
Hem. 1991 ; 37 (2) : 126-127. PubMed | Google
Scholar
- Lown R, Rhodes E, BosworthJ, Shannon MS, Stasi R. Acquired
amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor
agonists. Clin Adv Hematol Oncol. 2010 Nov;8(11):809-12. PubMed | Google
Scholar
- Felderbauer P, Ritter PR, Mattern D, Schmitz F, Bulut
K, Ansorge N et al. Acquired pure megakaryocytic aplasia: a separate haematological
disease entity or a syndrome with multiple causes. Eur J Haematol. 2004 Jun;72(6):451-4. PubMed | Google
Scholar
- Lai DW, Loughran TP, Maciejewski JP, Sasu S, Song SX, Epling-Burnette PK et al. Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia. Leuk Res. 2008 May;32(5):823-7. PubMed | Google Scholar
- Erkurt MA, Kaya E, Baran M, Tmen EY, Fienel S, Kuku R
et al. Rapid progression of acquired amegakaryocytic thrombocytopenia to myelodysplastic
syndrome: case report. Turk J Haematol. 2005;22(4): 205-208. PubMed | Google
Scholar
- Mulroy E, Gleeson S, Chiruka S, Danazol. Effective option
in acquired Amegakaryocytic thrombocytopaenic purpura; Case Rep. Hematol. 2015;2015:171253. PubMed | Google
Scholar
- Mirzania M, Khalili S, Hasanpoor A, Shamshiri RA. Anti-CD20
antibody is effective in the patient with refractory amegakaryocytic thrombocytopenia,
25 months follow up. Int J Hematol Oncol Stem Cell Res. 2014; 8(2): 41-44. PubMed | Google
Scholar
- Cela I, Miller IJ, Katz RS, Rizman A, Shammo JM .Successful
treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient
with Systemic Lupus Erythematosus (SLE). Clin Adv Hematol Oncol. 2010 Nov;8(11):809-12. PubMed | Google
Scholar